FI906249A0 - Foerfarande foer framstaellning av en farmaceutisk komposition. - Google Patents

Foerfarande foer framstaellning av en farmaceutisk komposition.

Info

Publication number
FI906249A0
FI906249A0 FI906249A FI906249A FI906249A0 FI 906249 A0 FI906249 A0 FI 906249A0 FI 906249 A FI906249 A FI 906249A FI 906249 A FI906249 A FI 906249A FI 906249 A0 FI906249 A0 FI 906249A0
Authority
FI
Finland
Prior art keywords
pharmaceutisk
komposition
foerfarande foer
foer framstaellning
framstaellning
Prior art date
Application number
FI906249A
Other languages
English (en)
Other versions
FI906249A (fi
Inventor
Kenichi Iwamitsu
Yukio Nakamura
Masahiro Kawasaki
Yoshio Fukui
Original Assignee
Nissho Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18278891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI906249(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nissho Kk filed Critical Nissho Kk
Publication of FI906249A0 publication Critical patent/FI906249A0/fi
Publication of FI906249A publication Critical patent/FI906249A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI906249A 1989-12-21 1990-12-18 Foerfarande foer framstaellning av en farmaceutisk komposition. FI906249A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33457189 1989-12-21

Publications (2)

Publication Number Publication Date
FI906249A0 true FI906249A0 (fi) 1990-12-18
FI906249A FI906249A (fi) 1991-06-22

Family

ID=18278891

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906249A FI906249A (fi) 1989-12-21 1990-12-18 Foerfarande foer framstaellning av en farmaceutisk komposition.

Country Status (7)

Country Link
US (1) US5095037B1 (fi)
EP (1) EP0433817B1 (fi)
CA (1) CA2031880C (fi)
DE (1) DE69003229T2 (fi)
ES (1) ES2059965T3 (fi)
FI (1) FI906249A (fi)
NO (1) NO177525C (fi)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
JP2829794B2 (ja) * 1991-02-08 1998-12-02 エスエス製薬 株式会社 徐放性経口投与型プラノプロフェン製剤
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5817642A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Clearing of atherosclerosis
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
CA2122551A1 (en) * 1994-04-29 1995-10-30 Rudolf Edgar Falk Clearing of atherosclerosis
JPH06509099A (ja) * 1991-07-03 1994-10-13 サノ・コーポレーシヨン ジクロフエナツクの経皮デリバリーに対する組成物及び方法
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US6136793A (en) * 1992-02-20 2000-10-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
CA2094203A1 (en) * 1993-04-16 1994-10-17 Derek A. Willoughby Inhibition of angiogenesis
US5847002A (en) * 1993-04-16 1998-12-08 Hyal Pharmaceutical Corporation Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
US20030008396A1 (en) * 1999-03-17 2003-01-09 Ku David N. Poly(vinyl alcohol) hydrogel
NZ512676A (en) 1999-01-13 2003-01-31 Meditech Res Ltd A composition and method for the enhancement of the efficacy of drugs
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US6576226B1 (en) 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
CA2436739A1 (en) * 2000-12-26 2002-07-04 Takeda Chemical Industries, Ltd. Combination agent
WO2002074318A1 (fr) * 2001-03-15 2002-09-26 Seikagaku Corporation Agents de regulation d'expression d'il-12
EP1406571A4 (en) * 2001-06-25 2007-05-30 Depuy Int Ltd LIPOSOMAL ENCAPSULATION OF GLYCOSAMINOGLYCANS FOR THE TREATMENT OF ARTHROSIS JOINTS
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN1578677A (zh) * 2001-08-27 2005-02-09 美迪泰克研究有限公司 改良的治疗方案
NZ531226A (en) * 2001-08-30 2006-07-28 Merckle Gmbh Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
JP2005530768A (ja) * 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
EA200602199A1 (ru) * 2004-01-20 2007-04-27 Панацея Биотек Лтд. Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство
AU2005212339B2 (en) * 2004-02-06 2010-11-25 Georgia Tech Research Corporation Load bearing biocompatible device
CA2558623C (en) 2004-02-06 2013-04-16 Georgia Tech Research Corporation Surface directed cellular attachment
US7956180B2 (en) * 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
CA2567722C (en) * 2004-05-27 2013-06-18 Novozymes Biopolymer A/S A dried and agglomerated hyaluronic acid product
US20050278025A1 (en) * 2004-06-10 2005-12-15 Salumedica Llc Meniscus prosthesis
US20060122150A1 (en) * 2004-09-30 2006-06-08 Argentieri Dennis C Pharmaceutical composition and method for treating a joint-capsule arthropathy
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
CN103784960A (zh) 2005-07-27 2014-05-14 阿尔卡米亚肿瘤学股份有限公司 使用乙酰透明质酸的治疗方案
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US8623354B2 (en) * 2005-09-07 2014-01-07 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
US8598144B1 (en) 2005-11-10 2013-12-03 Reyn Pharma, Llc Method of administering hyaluronan formulation for the amelioration of osteoarthritis
US9492381B1 (en) 2005-11-10 2016-11-15 Reyn Pharma, Llc Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis
CN101522164B (zh) * 2006-09-13 2014-03-26 提升肤质产品公司 用于治疗皮肤的化妆品组合物及其方法
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
FR2918476B1 (fr) * 2007-07-02 2012-08-03 Experts Enlargement Quality Exeq Controle de conformite de donnees.
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8178511B1 (en) * 2008-07-02 2012-05-15 Smith James D Method of administering hyaluronan formulation for the amelioration of osteopenia
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
FR2945949B1 (fr) * 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
TWI382841B (zh) * 2010-10-29 2013-01-21 Univ China Medical 用於抑制發炎之醫藥組合物
WO2012162552A1 (en) 2011-05-26 2012-11-29 Cartiva, Inc. Tapered joint implant and related tools
ES2667854T3 (es) * 2011-07-07 2018-05-14 Holy Stone Healthcare Co., Ltd. Composición para uso en el tratamiento y la prevención de trastornos relacionados con la inflamación
WO2016161025A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
WO2016161026A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Carpometacarpal (cmc) implants and methods
AU2016248062B2 (en) 2015-04-14 2020-01-23 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes

Also Published As

Publication number Publication date
EP0433817B1 (en) 1993-09-08
EP0433817A1 (en) 1991-06-26
DE69003229D1 (de) 1993-10-14
NO177525C (no) 2000-09-07
NO905514L (no) 1991-06-24
ES2059965T3 (es) 1994-11-16
CA2031880A1 (en) 1991-06-22
FI906249A (fi) 1991-06-22
US5095037A (en) 1992-03-10
DE69003229T2 (de) 1994-04-14
NO177525B (no) 1995-06-26
US5095037B1 (en) 1995-12-19
CA2031880C (en) 1999-09-21
NO905514D0 (no) 1990-12-20

Similar Documents

Publication Publication Date Title
FI890552A0 (fi) Maetning av blodets sammansaettning.
FI906249A (fi) Foerfarande foer framstaellning av en farmaceutisk komposition.
FI890429A (fi) Foerfarande foer framstaellning av vaeteperoxid.
FI83359B (fi) Foerfarande foer framstaellning av en takskiva.
FI890463A (fi) Foerfarande foer detektering av metallstycken.
FI890765A (fi) Nytt foerfarande foer framstaellning av en polymeriseringskatalysatorkomponent foer olefiner.
FI890428A0 (fi) Foerfarande foer framstaellning av vaeteperoxid.
FI890963A0 (fi) Foerfarande foer behandling av braenngas producerad av avlutar fraon alkaliska cellulosaprocesser.
FI86245B (fi) Foerfarande foer tillverkning av en konserv.
FI890057A (fi) Anordning foer vaendning av buntar.
FI890025A0 (fi) Anordning foer lottning av lottonummer.
FI890061A0 (fi) Foerfarande foer styrning av en mekanisk resonanshand.
FI890212A (fi) Anordning foer odling av mikroorganismer.
FI890222A (fi) Foerfarande foer framstaellning av granulerade peroxidfoereningar.
FI890330A0 (fi) Foerfarande foer framstaellning av laminatmaterial.
FI890360A (fi) Anlaeggning foer roekning av livsmedel.
FI890371A (fi) Gripanordning foer en gaffeltruck foer lyftning av en rullpall.
FI890378A0 (fi) Knivarrangemang foer framstaellning av granultorv.
FI890397A0 (fi) Industriell framstaellning av torrkoett.
FI890962A0 (fi) Foerfarande foer behandling av braenngas producerad av avlutar fraon alkaliska cellulosaprocesser.
FI890023A0 (fi) Stroemkrets foer aostadkommande av stroembegraensad spaenningstillfoersel.
FI890546A0 (fi) Anordning foer tillverkning av en katsa.
FI890018A0 (fi) Presshuvud foer framstaellning av rostskyddande roerformad polymerfolie.
FI890596A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara oxadiazolyl-azabicykloheptaner.
FI890597A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara lipofiliska oxadiazoler.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: NISSHO CORPORATION